- Home
- SWZ vs FBIO Comparison
SWZ vs FBIO Comparison
Compare SWZ & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWZ
- FBIO
- Stock Information
- Founded
- SWZ 1986
- FBIO 2006
- Country
- SWZ United States
- FBIO United States
- Employees
- SWZ N/A
- FBIO N/A
- Industry
- SWZ Finance Companies
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SWZ Finance
- FBIO Health Care
- Exchange
- SWZ Nasdaq
- FBIO Nasdaq
- Market Cap
- SWZ 78.7M
- FBIO 88.7M
- IPO Year
- SWZ N/A
- FBIO N/A
- Fundamental
- Price
- SWZ $5.99
- FBIO $2.50
- Analyst Decision
- SWZ
- FBIO Strong Buy
- Analyst Count
- SWZ 0
- FBIO 2
- Target Price
- SWZ N/A
- FBIO $16.50
- AVG Volume (30 Days)
- SWZ 14.2K
- FBIO 701.2K
- Earning Date
- SWZ 01-01-0001
- FBIO 11-13-2025
- Dividend Yield
- SWZ 6.59%
- FBIO N/A
- EPS Growth
- SWZ N/A
- FBIO N/A
- EPS
- SWZ N/A
- FBIO N/A
- Revenue
- SWZ N/A
- FBIO $59,301,000.00
- Revenue This Year
- SWZ N/A
- FBIO $31.85
- Revenue Next Year
- SWZ N/A
- FBIO $44.43
- P/E Ratio
- SWZ N/A
- FBIO N/A
- Revenue Growth
- SWZ N/A
- FBIO N/A
- 52 Week Low
- SWZ $7.12
- FBIO $1.33
- 52 Week High
- SWZ $8.57
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- SWZ 34.26
- FBIO 37.08
- Support Level
- SWZ $5.98
- FBIO $2.48
- Resistance Level
- SWZ $6.08
- FBIO $2.61
- Average True Range (ATR)
- SWZ 0.08
- FBIO 0.13
- MACD
- SWZ 0.00
- FBIO -0.04
- Stochastic Oscillator
- SWZ 20.83
- FBIO 5.81
About SWZ Swiss Helvetia Fund Inc. (The)
Swiss Helvetia Fund Inc is a non-diversified, closed-end investment company. Its investment objective is to seek long-term capital appreciation through investment in equity and equity-linked securities of Swiss companies. The group invests in various sectors such as pharmaceuticals, food and beverage, industrial goods and services, banks, personal and household goods, construction and materials, biotechnology, medical equipment, chemicals, technology, financial services, insurance, Semiconductors, Information Technology, and retail.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.